Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix Percutaneous Mechanical Circulatory Support Technology
Technology to be evaluated in acute decompensated heart failure patients, where current treatment options remain ineffective and lacking
United States Erics Fain Bassem Chehab Gillian Grafton Procyrion Inc Journal Of The American College Cardiology
Source: dicardiology.com